Evidence map›Paper›PMID 18798293›Full record

ArticleLasers in surgery and medicine2008

Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy.

Henry Hirschberg, Francisco A Uzal, David Chighvinadze, Michelle J Zhang, Qian Peng, Steen J Madsen

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Lasers in surgery and medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02474966 (Effects of Deep Transcranial Magnetic Stimulation on the Permeability of the Blood-brain Barrier in Patients With Glioblastoma Multiforme), which is not on this map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02474966 phase2completednot on this mapstarted 2014, after this paper: background citation

Effects of Deep Transcranial Magnetic Stimulation on the Permeability of the Blood-brain Barrier in Patients With Glioblastoma Multiforme: a Pilot Study

TypeinterventionalSponsorUniversity of Roma La SapienzaRan2014 to 2015Enrolled15ConditionsGlioblastoma Multiforme of BrainArmsDeep Transcranial Magnetic Stimulation (dTMS)
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 82 citations in OpenAlex.

  1. Review
  2. Activatable Photosensitizers: From Fundamental Principles to Advanced Designs.Angewandte Chemie (International ed. in English) · 2025
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Photodynamic opening of blood-brain barrier.Biomedical optics express · 2017
    Article
  18. Cell Mediated Photothermal Therapy of Brain Tumors.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Henry HirschbergBeckman Laser Institute, University of California, Irvine, California 92612, USA. hhirschb@uci.edu
Francisco A Uzal
David Chighvinadze
Michelle J Zhang
Qian Peng
Steen J Madsen
University of Nevada, Las Vegas · USBeckman Laser Institute and Medical Clinic · USNorwegian Cancer Society · NOUniversity of California, Davis · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
WOUND MIGRATION FORCE MONITORINGP41RR001192 · NCRR · UNIVERSITY OF CALIFORNIA-IRVINE · PI LYUBOVITSKY, JULIA · 1985 to 2011
$14.2M
NCI NIH HHS CA-62203NCI NIH HHS P30 CA062203NCRR NIH HHS P41 RR001192NCRR NIH HHS RR-01192
6 · The paper itself

Abstract

BACKGROUND AND

objectivePhotodynamic therapy (PDT) is a local antineoplastic treatment with the potential for tumor cell specificity. PDT using either hematoporphyrin derivatives or 5-aminolevulinic acid (ALA) has been reported to induce brain edema indicating disruption of the blood-brain barrier (BBB). We have evaluated the ability of ALA-mediated PDT to open the BBB in rats. This will permit access of chemotherapeutic agents to brain tumor cells remaining in the resection cavity wall, but limit their penetration into normal brain remote from the site of illumination. STUDY DESIGN/MATERIALS AND

methodsALA-PDT was performed on non-tumor bearing inbred Fischer rats at increasing fluence levels. Contrast T(1)-weighted high field (3 T) magnetic resonance imaging (MRI) scans were used to monitor the degree of BBB disruption which could be inferred from the intensity and volume of the contrast agent visualized.

resultsPDT at increasing fluence levels between 9 and 26 J demonstrated an increasing contrast flow rate. A similar increased contrast volume was observed with increasing fluence rates. The BBB was found to be disrupted 2 hours following PDT and 80-100% restored 72 hours later at the lowest fluence level. No effect on the BBB was observed if 26 J of light was given in the absence of ALA.

conclusionALA-PDT was highly effective in opening the BBB in a localized region of the brain. The degradation of the BBB was temporary in nature at fluence levels of 9 J, opening rapidly following treatment and significantly restored during the next 72 hours. No signs of tissue damage were seen on histological sections at this fluence level. However, higher fluences did demonstrate permanent tissue changes localized in the immediate vicinity of the light source.

Indexed as

Magnetic Resonance ImagingPhotochemotherapyAminolevulinic AcidAnimalsBlood-Brain BarrierMalePhotosensitizing AgentsRatsRats, Inbred F344Aminolevulinic AcidPhotosensitizing Agents

Identifiers

PMID18798293
PMCPMC2667623
OpenAlexW2094357205

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.